Breaking News Instant updates and real-time market news.

APTX

Aptinyx

$3.78

-0.015 (-0.40%)

06:28
05/14/19
05/14
06:28
05/14/19
06:28

Aptinyx reports Q1 EPS (50c), consensus (45c)

Reports Q1 revenue $900,000, consensus $1.12M. Cash and cash equivalents were $136.6M at March 31 compared to $150.6M at December 31, 2018.

  • 14

    May

  • 15

    May

APTX Aptinyx
$3.78

-0.015 (-0.40%)

01/17/19
LEER
01/17/19
NO CHANGE
Target $22
LEER
Outperform
Aptinyx price target lowered to $22 from $35 at Leerink
Leerink analyst Geoffrey Porges lowered his price target for Aptinyx to $22 from $35 following the negative result from the phase II study for NYX-2925 in diabetic peripheral neuropathy. The analyst reiterates an Outperform rating on Aptinyx shares as the stock is currently trading around cash levels and further data disclosures from DPN, fibromyalgia, PTSD, and Parkinson's disease cognitive impairment programs later this year could clarify the various opportunities for the company's drug discovery platform.
01/18/19
BMOC
01/18/19
NO CHANGE
Target $18
BMOC
Outperform
Aptinyx price target lowered to $18 from $32 at BMO Capital
BMO Capital analyst Gary Nachman lowered his price target on Aptinyx to $18 after its negative result from the phase II study for NYX-2925 in diabetic peripheral neuropathy that "failed to achieve statistical significance on the primary endpoint." The analyst keeps his Outperform rating however and points to the management's "silver lining" of the drug's 50mg dose trending favorably "in a subset not on concomitant medication." Nachman adds that the program still offers "options to move forward with NYX-2925 in chronic pain" patients.
03/22/19
CANT
03/22/19
NO CHANGE
Target $12
CANT
Overweight
Aptinyx price target lowered to $12 from $18 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan lowered his price target for Aptinyx to $12 from $18 following the company's Q4 results and reiterates an Overweight rating on the shares. The target reduction reduction reflects the "overhang" created by the DPN Phase 2 readout, expectations of modest benefit in the fibromyalgia trial reading out in the first half of 2018, and the recent rapastinel trial outcome in depression that raises concerns with Aptinyx's platform more broadly, Duncan tells investors in a research note.
03/22/19
BMOC
03/22/19
NO CHANGE
Target $15
BMOC
Outperform
Aptinyx price target lowered to $15 from $18 at BMO Capital
BMO Capital analyst Gary Nachman lowered his price target on Aptinyx to $15 to reflect his longer-term revenue model adjustments, with "additional conservatism" built in for NYX-2925 after its phase 2 trial data suggested that the program is now geared to more advanced diabetic peripheral neuropathy. The analyst is keeping his Outperform rating on Aptinyx shares however, noting that the company's latest quarter results were better-than-expected on lower spending, while its $151M cash position is expected to last the company into 2021.

TODAY'S FREE FLY STORIES

AAPL

Apple

$187.49

4.43 (2.42%)

14:31
05/21/19
05/21
14:31
05/21/19
14:31
Periodicals
Apple expands keyboard repair program to include butterfly mechanism, Verge says »

Apple is updating its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

CC

Chemours

$23.77

1.35 (6.02%)

14:30
05/21/19
05/21
14:30
05/21/19
14:30
Options
5K Chemours Oct 16 - 20 put spreads bought for 92c as shares rally »

5K Chemours Oct 16 - 20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
05/21/19
05/21
14:25
05/21/19
14:25
Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

QRVO

Qorvo

$62.14

0.84 (1.37%)

14:22
05/21/19
05/21
14:22
05/21/19
14:22
Recommendations
Qorvo analyst commentary at Oppenheimer »

Qorvo could be first to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

14:21
05/21/19
05/21
14:21
05/21/19
14:21
Hot Stocks
PEDEVCO Corp. announces sale of stock to SK Energy, two unaffiliated investors »

PEDEVCO Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

14:20
05/21/19
05/21
14:20
05/21/19
14:20
Hot Stocks
Breaking Hot Stocks news story on PEDEVCO Corp. »

PEDEVCO Corp. trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/21/19
05/21
14:17
05/21/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/21/19
05/21
14:16
05/21/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$127.09

0.9 (0.71%)

, AAPL

Apple

$187.52

4.46 (2.44%)

14:15
05/21/19
05/21
14:15
05/21/19
14:15
Periodicals
Microsoft cuts Huawei laptop from store, Verge says »

According to a story from…

MSFT

Microsoft

$127.09

0.9 (0.71%)

AAPL

Apple

$187.52

4.46 (2.44%)

HPQ

HP Inc.

$19.55

0.6 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

BCRX

BioCryst

$3.45

-3.95 (-53.38%)

14:13
05/21/19
05/21
14:13
05/21/19
14:13
Recommendations
BioCryst analyst commentary at JMP Securities »

BioCryst pullback an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

XRX

Xerox

$32.83

0.705 (2.19%)

14:12
05/21/19
05/21
14:12
05/21/19
14:12
Hot Stocks
Xerox shareholders approve holding company reorganization »

Xerox announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

YELP

Yelp

$32.36

0.65 (2.05%)

14:10
05/21/19
05/21
14:10
05/21/19
14:10
Options
Bullish option flow in Yelp »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 27

    Jun

PED

PEDEVCO Corp.

$2.02

-0.06 (-2.88%)

13:51
05/21/19
05/21
13:51
05/21/19
13:51
Hot Stocks
Breaking Hot Stocks news story on PEDEVCO Corp. »

PEDEVCO Corp. trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$42.87

12.23 (39.92%)

13:47
05/21/19
05/21
13:47
05/21/19
13:47
Hot Stocks
Breaking Hot Stocks news story on Circor 

CIRCOR trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYDS

Payment Data Systems

$2.30

0.18 (8.49%)

13:46
05/21/19
05/21
13:46
05/21/19
13:46
Hot Stocks
Payment Data Systems jumps over 7% after announcing pact with Pineapple Payments »

Earlier on Tuesday,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

  • 11

    Jun

FLR

Fluor

$29.94

0.48 (1.63%)

13:45
05/21/19
05/21
13:45
05/21/19
13:45
Options
Fluor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 13

    Jun

GOOD

Gladstone

$21.61

0.165 (0.77%)

13:41
05/21/19
05/21
13:41
05/21/19
13:41
Recommendations
Gladstone analyst commentary at Ladenburg »

Gladstone's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

CIR

Circor

$42.96

12.32 (40.21%)

, CR

Crane

$83.27

-1.62 (-1.91%)

13:33
05/21/19
05/21
13:33
05/21/19
13:33
Hot Stocks
Circor again rejects Crane bid, says it 'substantially' undervalues company »

Circor International…

CIR

Circor

$42.96

12.32 (40.21%)

CR

Crane

$83.27

-1.62 (-1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$42.96

12.32 (40.21%)

, CR

Crane

$83.27

-1.62 (-1.91%)

13:30
05/21/19
05/21
13:30
05/21/19
13:30
Hot Stocks
Breaking Hot Stocks news story on Circor, Crane »

Circor 'reiterates…

CIR

Circor

$42.96

12.32 (40.21%)

CR

Crane

$83.27

-1.62 (-1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$48.03

0.52 (1.09%)

13:30
05/21/19
05/21
13:30
05/21/19
13:30
Periodicals
MetLife in talks to sell central European assets to Generali, Bloomberg says »

The business being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 18

    Jun

  • 18

    Jun

PXD

Pioneer Natural

$157.52

3.29 (2.13%)

13:26
05/21/19
05/21
13:26
05/21/19
13:26
Hot Stocks
Pioneer Natural backs Q2 Permian production view 313-328 MBOEPD »

Backs Q2 Permian oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Aug

CMCSA

Comcast

$43.15

0.37 (0.86%)

, CMCSK

Comcast

$0.00

(0.00%)

13:25
05/21/19
05/21
13:25
05/21/19
13:25
Periodicals
Comcast working on device similar to Amazon Echo, focused on health, CNBC says »

Comcast (CMCSA, CMCSK) is…

CMCSA

Comcast

$43.15

0.37 (0.86%)

CMCSK

Comcast

$0.00

(0.00%)

AMZN

Amazon.com

$1,853.86

-4.95 (-0.27%)

GOOG

Alphabet

$1,151.98

13.65 (1.20%)

GOOGL

Alphabet Class A

$1,157.99

12.71 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 03

    Jun

  • 05

    Jun

  • 19

    Jun

  • 19

    Jun

  • 24

    Jun

  • 27

    Oct

CIR

Circor

$43.01

12.37 (40.37%)

13:25
05/21/19
05/21
13:25
05/21/19
13:25
Hot Stocks
Breaking Hot Stocks news story on Circor »

CIRCOR trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PXD

Pioneer Natural

$157.52

3.29 (2.13%)

13:25
05/21/19
05/21
13:25
05/21/19
13:25
Hot Stocks
Pioneer Natural sees FY19 Permian production 320-335 MBOEPD »

Sees FY19 cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Aug

13:25
05/21/19
05/21
13:25
05/21/19
13:25
General news
Treasury Action: shorter dated Treasuries continue to erode »

Treasury Action: shorter…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.